GlassScriptPhysician profile
Jacque Y Curtis
NPI 1598784324
$622.06
in general payments reported to CMS, 2019-2025
13 companies · $68.51 in 2025
The $68.51 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $22.99 · 2022: $145 · 2023: $36.76 · 2024: $95.09 · 2025: $68.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $238.99 | 2019-2023 | Trelegy Ellipta |
| Abbvie INC. | $65.14 | 2022 | |
| Gilead Sciences, INC. | $56.18 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $48.63 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $40.03 | 2019 | |
| Novo Nordisk INC | $38.49 | 2019-2025 | Ozempic |
| Pfizer INC. | $28.78 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $21.60 | 2024 | Pifeltro, Delstrigo |
| Xeris Pharmaceuticals, INC. | $20.77 | 2025 | Recorlev |
| Shire North American Group INC | $18.91 | 2019 | |
| Qiagen, LLC | $17.31 | 2024 | |
| Exact Sciences Corporation | $13.87 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $13.36 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacque Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.